Concepedia
Statistics
Publications
7
Citations
272
H-Index
Active since
2018
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Cornell University
Stanford University
Boston University
Andrew Keezer is an author at Dana-Farber Cancer Institute specializing in oncology, life sciences, and clinical immunology.
Publications per year
2018–2020
<i>CXCR4</i> mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
Jorge J. Castillo, Lian Xu, Joshua Gustine et al. · British Journal of Haematology · 2019 · 103 citations · Full text
Medicine, Molecular Genetics, Oncology +6
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi, Xia Liu, Jiaji G. Chen et al. · Blood Cancer Journal · 2020 · 46 citations · Full text
Life Sciences, Oncology, Pharmacology +14
CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia
Joshua Gustine, Lian Xu, Nicholas Tsakmaklis et al. · Blood Advances · 2019 · 39 citations · Full text
Life Sciences, Oncology, Pharmacology +10
Multicenter Prospective Phase II Study of Venetoclax in Patients with Previously Treated Waldenstrom Macroglobulinemia
Jorge J. Castillo, Joshua Gustine, Kirsten Meid et al. · Blood · 2018 · 38 citations
Pharmacy, Hematology, Pharmacotherapy +2
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas
Xia Liu, Jiaji G. Chen, Manit Munshi et al. · Blood Advances · 2020 · 24 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +16
1–5 of 7